ustekinumab
SpainDrugs containing this active substance
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 5 mg/ml Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg/ml Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 130 mg Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg/ml Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Fresenius Kabi Deutschland Gmbh
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis (moderate to severe), psoriatic arthritis, and Crohn's disease (moderate to severe).
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Samsung Bioepis Nl B.V.
-
It is used to treat moderate to severe Crohn's disease and moderate to severe ulcerative colitis in adults.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 135 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), Crohn's disease (in adults), and ulcerative colitis (in adults).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat inflammatory diseases in adults, such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg Manufacturer: Janssen-Cilag International N.V
-
How should I store the medication?:
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat inflammatory diseases in adults, such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), Crohn's disease (in adults), and ulcerative colitis (in adults).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg Manufacturer: Celltrion Healthcare Hungary Kft.
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg Manufacturer: Gedeon Richter Plc.
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Gedeon Richter Plc.
-
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in pre-filled syringe
Active substance Dosage ustekinumab 90 mg/ml Manufacturer: Gedeon Richter Plc.
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 130 mg Manufacturer: Stada Arzneimittel Ag
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 45 mg Manufacturer: Stada Arzneimittel Ag
-
What is Uzpruvo used for?": "It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).", "How should I take Uzpruvo?": "It is administered via a subcutaneous injection. Your doctor will decide the dose and the duration of treatment. For psoriasis or psoriatic arthritis, the initial dose is usually 45 mg (or 90 mg if you weigh more than 100 kg), with subsequent doses every 12 weeks. In Crohn's disease, the first dose may be administered intravenously and subsequent doses via subcutaneous injection.", "When should I not use this medicine?": "You should not use it if you are allergic to ustekinumab or any of its components, or if you have an active infection that your doctor considers significant.", "What side effects can Uzpruvo cause?": "It may cause common side effects such as diarrhea, nausea, vomiting, fatigue, dizziness, headache, or itching. Serious side effects may also occur, such as allergic reactions (difficulty breathing or swelling), infections (colds, chest infections, or skin infections), and, in rare cases, heart problems or heart attacks.", "What should I tell my doctor before starting treatment?": "You must inform your doctor if you have had allergic reactions, if you have had cancer, if you have received biological treatments for psoriasis, if you have recent infections, if you are taking other medications, or if you are pregnant or breastfeeding.", "How should I store the medicine?": "It must be stored in a refrigerator between 2 °C and 8 °C, do not freeze. It can be stored at room temperature (up to 30 °C) for a maximum of 30 days in its original box to protect it from light."
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Stada Arzneimittel Ag
-
It is used to treat moderate to severe Crohn's disease in adults and in children weighing at least 40 kg.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 90 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used to treat plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used in adults to treat inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 45 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used to treat inflammatory diseases in adults, specifically plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease.
Form: solution for injection in pre-filled pen
Active substance Dosage ustekinumab 90 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and Crohn's disease (in adults and children weighing at least 40 kg).
Form: solution for injection
Active substance Dosage ustekinumab 90 mg Manufacturer: Amgen Technology (Ireland) Unlimited Company
-
It is used to treat moderate to severe Crohn's disease in adults, specifically when other medications have not worked adequately or cannot be tolerated.
Form: solution for infusion, concentrate
Active substance Dosage ustekinumab 5 mg/ml Manufacturer: Biosimilar Collaborations Ireland Limited
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults).
Form: solution for injection
Active substance Dosage ustekinumab 45 mg Manufacturer: Biosimilar Collaborations Ireland Limited
-
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults).
Form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg Manufacturer: Biosimilar Collaborations Ireland Limited